Related Experiment Video
Updated: May 29, 2026
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
Published on: June 7, 2020
Emerging insights into the molecular biology of brain metastases
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
Abstract:
One of the foremost challenges in oncology is developing improved therapies for preventing and treating metastases to the brain. Recent research in this area is bringing about a shift in the understanding of brain metastases. Previously, the occurrence and poor outcomes associated with brain metastases have been largely attributed to the exclusion of anticancer drugs from the brain by the blood-brain barrier (BBB). However, studies in multiple tumor types have also demonstrated that brain metastases have significant molecular differences from primary tumors and extracranial metastases. These molecular differences may not only promote the formation of brain metastases, but they may also contribute to these tumors' poor responsiveness to therapies. Such changes may be intrinsic to the cancer cells or driven by unique interactions with the brain microenvironment. An improved understanding of the molecular characteristics of brain metastases that contribute to their aggressive behaviors will facilitate the development of rational, more effective treatments for these tumors.
Insights
Developing new brain metastases therapies is crucial. Research shows these tumors have unique molecular traits, distinct from primary cancers, impacting treatment effectiveness.
Area of Science:
- Oncology
- Neuro-oncology
- Cancer Metastasis Research
Background:
- Brain metastases present a significant challenge in cancer care, often leading to poor patient outcomes.
- The blood-brain barrier (BBB) was historically considered the primary obstacle for drug delivery to the brain.
- Emerging research indicates molecular differences in brain metastases contribute to their development and treatment resistance.
Purpose of the Study:
- To re-evaluate the understanding of brain metastases beyond the blood-brain barrier's role.
- To investigate the molecular characteristics of brain metastases and their impact on therapeutic response.
- To highlight the need for targeted therapies based on brain metastases' unique biology.
Main Methods:
- Review of recent studies on brain metastases across various tumor types.
- Comparative analysis of molecular profiles between primary tumors, extracranial metastases, and brain metastases.
- Investigation into the role of the brain microenvironment in shaping metastasis characteristics.
Main Results:
- Brain metastases exhibit distinct molecular profiles compared to primary and extracranial tumors.
- These molecular differences are implicated in the formation and aggressive behavior of brain metastases.
- Intrinsic cancer cell changes and brain microenvironment interactions drive these unique characteristics.
Conclusions:
- Understanding the specific molecular features of brain metastases is key to improving treatment strategies.
- Future therapies should consider the unique biology of brain metastases for enhanced efficacy.
- A shift in focus from solely the blood-brain barrier to tumor-intrinsic and microenvironment factors is necessary.
